Xu et al. demonstrated significantly higher expression of serum MASP-2 in patients with SLE along with MASP-2 gene polymorphism, compared to NHCs and other rheumatic diseases including rheumatoid arthritis, osteoarthritis, Sjogren's syndrome, and ankylosing spondylitis. The gene discussed is MASP2; the disease is Sjogren syndrome.